Extended Release Orally Disintegrating Dosage Forms are Potential Techniques to Deliver and Maintain the Therapeutic Ranges of Plasma Drug Concentrations
Taha Nazir*
Intellectual Consortium of Drug Discovery & Technology Development Incorporation, Saskatoon SK S7L3E4 Canada
*Corresponding author: Taha Nazir, Intellectual Consortium of Drug Discovery & Technology Development Incorporation, Saskatoon SK S7L3E4 Canada, Tel: +92 321
222 0885; E-mail: [email protected]; [email protected]
Received date: October 02, 2014; Accepted date: October 06, 2015; Published date: October 15, 2015
Intellectual Consortium of Drug Discovery & Technology Development Incorporation, Saskatoon SK S7L3E4 Canada
*Corresponding author: Taha Nazir, Intellectual Consortium of Drug Discovery & Technology Development Incorporation, Saskatoon SK S7L3E4 Canada, Tel: +92 321
222 0885; E-mail: [email protected]; [email protected]
Received date: October 02, 2014; Accepted date: October 06, 2015; Published date: October 15, 2015